Ranbaxy Laboratories Ltd (RANB.NS)

RANB.NS on National Stock Exchange of India

644.70INR
10:22am IST
Price Change (% chg)

Rs-3.90 (-0.60%)
Prev Close
Rs648.60
Open
Rs651.80
Day's High
Rs651.80
Day's Low
Rs643.80
Volume
137,433
Avg. Vol
1,132,647
52-wk High
Rs662.35
52-wk Low
Rs302.00

RANB.NS

Chart for RANB.NS

About

Ranbaxy Laboratories Limited is an integrated international pharmaceuticals company. The Company is engaged in the marketing, production and distribution of pharmaceutical products. The Company’s business activity falls within a single primary business segment viz. Pharmaceutical. The Company has ground operations in over 40... (more)

Overall

Beta: 0.74
Market Cap (Mil.): Rs276,901.91
Shares Outstanding (Mil.): 424.01
Dividend: --
Yield (%): --

Financials

  RANB.NS Industry Sector
P/E (TTM): -- 32.67 33.58
EPS (TTM): -20.63 -- --
ROI: -- 18.00 17.30
ROE: -- 18.64 18.05
Search Stocks

INDIA PRESS-Ranbaxy may have to pay fine in United States - Economic Times

Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Aby Jose Koilparambil in Bangalore)

22 Aug 2014

Pharma shares buck stock market trend, lead gainers

Reuters Market Eye - Drugmakers rose on Wednesday, bucking the stock market trend as investors seek defensives.

20 Aug 2014

INDIA PRESS-More exits from Ranbaxy Labs' top management team-Economic Times

Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Aby Jose Koilparambil in Bangalore)

20 Aug 2014

Ranbaxy posts loss on provision for U.S. settlement

MUMBAI - Generic drugmaker Ranbaxy Laboratories Ltd posted a net loss for the quarter to end-June after making a provision related to "ongoing settlement discussions" with U.S. government authorities.

29 Jul 2014

UPDATE 1-India's Ranbaxy posts loss on provision for US settlement

* Loss of 1.86 bln rupees due to one-off 2.4 bln provision

29 Jul 2014

India's Ranbaxy Laboratories posts loss in June quarter

MUMBAI, July 29 - Indian drugmaker Ranbaxy Laboratories Ltd, which has agreed to be acquired by local rival Sun Pharmaceutical Industries Ltd, posted a net loss in the June quarter hit by a one-time provision.

29 Jul 2014

Drugmaker Novartis to eke out more cost savings to lift margins

ZURICH - Swiss drugmaker Novartis posted a quarterly rise in sales that missed expectations and said it would focus on eking out gradual cost savings to boost margins as it prepares a radical business overhaul.

17 Jul 2014

India caps price of 108 more medicines; drugmakers to take hit

MUMBAI - India has capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV, a move likely to hit the profit margins of drug firms such as Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.

14 Jul 2014

UPDATE 1-India caps price of 108 more medicines; drugmakers to take hit

* Move aimed towards making drugs more affordable in India

14 Jul 2014

India caps prices of 108 more medicines; drugmakers to take hit

MUMBAI, July 14 - India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.

14 Jul 2014

Earnings vs. Estimates

Search Stocks